What is the best medical therapy for new-onset type 2 diabetes?

Journal of Family Practice

Volumn 55, Issue 11, 2006, Pages 998-1000

  Klam, Cheri ^a   Neher, Jon ^a   Mayo, Helen ^b  

^a Valley Family Medicine Residency   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; GLIMEPIRIDE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; METFORMIN; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA; ANTIDIABETIC AGENT;

CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; HUMAN; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; REVIEW; SYSTEMATIC REVIEW; COMPARATIVE STUDY; ECONOMICS; EVIDENCE BASED MEDICINE;

DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 33750989645     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 2002; 287:360-372.
2. Epocrates Drug Database. Available at: www2.epocrates.com/index.html. Accessed on May 18, 2006.
3. Yamanouchi T, Sakai T, Igarashi K, Ichiyanagi K, Watanabe H, Kawasaki T. Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes. Diabetic Med 2005; 22: 980-985.
4. Van de Laar FA, Lucassen PLBJ, Akkermans RP, Van de Lisdonk EH, Rutten GEHM, Can Weel C. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev 2005, Issue 2.
5. Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D. Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev 2005, Issue 3.
6. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34). Lancet 1998; 352:854-865.
7. DeFronzo RA, Bergenstal RM, Cefalu WT, et al. Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise. Diabetes Care 2005; 28:1922-1928.
8. IDF Clinical Guidelines Task Force, Global guideline for Type 2 diabetes. Brussels: International Diabetes Federation, 2005.
9. Institute for Clinical Systems Improvement (ICSI). Management of type 2 diabetes mellitus. Bloomington, Minn: Institute for Clinical Systems Improvement (ICSI); 2005 Nov. 79 p.
10. American Diabetes Association. Standard of medical care in diabetes-2006. Diabetes Care 2006; 29: S4-S42.